financetom
Business
financetom
/
Business
/
ING Previews Next Week's Bank of Canada Policy Meeting
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ING Previews Next Week's Bank of Canada Policy Meeting
Sep 2, 2024 3:04 PM

08:22 AM EDT, 08/30/2024 (MT Newswires) -- The Bank of Canada (BoC) initiated the current easing cycle at the June 5 meeting on the basis that "recent data has increased our confidence that inflation will continue to move towards the 2% target," noted ING.

This was followed up by a second cut on July 24, justified by data showing "broad price pressures continuing to ease" with "ongoing excess supply lowering inflationary pressures."

Since that meeting business survey responses have cooled further, employment has fallen for the second month in a row and inflation has slowed to 2.5% at the headline level, comfortably within the BoC's 1%-3% target range. Since unemployment has risen 1.6 percentage points since the July 2022 low, this underscores the BoC's point that the economy is now experiencing excess supply, wrote the bank in a note.

This excess supply will continue to depress inflation while the effect of previous interest rate increases will continue to impact demand, stated ING. In Canada, mortgages are fixed for a much shorter period of time than in the United States and this means households face higher borrowing costs when their mortgage rate resets higher.

In fact, debt service costs as a proportion of household income are at 30+ year highs, which will contribute to sluggish consumer spending with the economy as a whole expected to grow only 0.9% this year.

The bank is forecasting inflation to average 2% next year, so given these economic conditions ING sees scope for meaningful interest rate cuts.

The bank agrees with financial market pricing of another 25bps rate cut next Wednesday and targets a 3% overnight rate for Q2 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rani Therapeutics Files $200 Million Mixed Shelf
Rani Therapeutics Files $200 Million Mixed Shelf
Aug 8, 2025
04:30 PM EDT, 08/08/2025 (MT Newswires) -- Rani Therapeutics ( RANI ) filed a registration statement Friday for the potential sale of up to $200 million of securities from time to time in one or more offerings. The filing covers class A common shares, preferred stock, debt securities, and warrants. The company said it plans to use the net proceeds...
Alamos Gold Files $500 Million Mixed Shelf
Alamos Gold Files $500 Million Mixed Shelf
Aug 8, 2025
04:32 PM EDT, 08/08/2025 (MT Newswires) -- Alamos Gold ( AGI ) filed a registration statement for the sale of $500 million of securities. The securities cover common shares, debt securities, warrants, and subscription receipts, according to the filing. The company stated it plans to use the net proceeds for general corporate purposes. ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Arvinas, Pfizer Get US FDA New Drug Application Acceptance for Potential Breast Cancer Treatment
Arvinas, Pfizer Get US FDA New Drug Application Acceptance for Potential Breast Cancer Treatment
Aug 8, 2025
04:30 PM EDT, 08/08/2025 (MT Newswires) -- Arvinas ( ARVN ) and Pfizer ( PFE ) said late Friday the US Food and Drug Administration accepted the new drug application for vepdegestrant to treat patients with advanced breast cancer who have previously received endocrine-based therapy. The FDA assigned a Prescription Drug User Fee Act action date of June 5, 2026,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved